Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Non-Current Liabilities (2022 - 2024)

60 Degrees Pharmaceuticals (SXTP) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $565949.0 as the latest value for Q1 2024.

  • On a quarterly basis, Other Non-Current Liabilities fell 62.25% to $565949.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $565949.0, a 62.25% decrease, with the full-year FY2023 number at $75000.0, down 94.98% from a year prior.
  • Other Non-Current Liabilities was $565949.0 for Q1 2024 at 60 Degrees Pharmaceuticals, up from $75000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.5 million in Q1 2023 to a low of $75000.0 in Q4 2023.
  • A 3-year average of $908620.8 and a median of $1.0 million in 2022 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 94.98% in 2023, then crashed 62.25% in 2024.
  • 60 Degrees Pharmaceuticals' Other Non-Current Liabilities stood at $1.5 million in 2022, then plummeted by 94.98% to $75000.0 in 2023, then surged by 654.6% to $565949.0 in 2024.
  • Per Business Quant, the three most recent readings for SXTP's Other Non-Current Liabilities are $565949.0 (Q1 2024), $75000.0 (Q4 2023), and $1.5 million (Q1 2023).